SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-00-004145
Filing Date
2000-08-24
Accepted
2000-08-24 00:00:00
Documents
3
Period of Report
2000-08-18
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. e8-k.txt 8-K 3820
2 AGREEMENT AND PLAN OF MERGER ex99-1.txt EX-99.1 164798
3 PRESS RELEASE DATED AUGUST 21, 2000 ex99-2.txt EX-99.2 8152
  Complete submission text file 0000950135-00-004145.txt   178624
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 708875
SIC: 2836 Biological Products, (No Diagnostic Substances)